NASDAQ : SCNX
Scienture Holdings, Inc. — Financial statements
Healthcare · Pharmaceutical Retailers · United States
Last price 3.49 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 5.73M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Scienture Holdings, Inc. (SCNX) reported revenue of 821.32K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | 821.32K | 431.61K | 136.64K | 1.36M | 300.00K |
| Cost of Revenue | 100.88K | 100.13K | 130.64K | 1.31M | |
| Gross Profit | 720.44K | 331.48K | 6.00K | 49.03K | 300.00K |
| Selling, General & Admin | 11.95M | 14.62M | 12.47M | 4.45M | 880.11K |
| Research & Development | 2.50M | 1.96M | 2.24M | 3.06M | |
| Operating Expenses | 14.45M | 16.58M | 14.71M | 4.45M | 3.94M |
| Operating Income | -13.72M | -16.24M | -14.70M | -4.40M | -3.64M |
| Interest Expense | -3.07M | -4.08M | -1.34M | -1.14M | -76.35K |
| Interest & Investment Income | 494.60K | 302.70K | 135.34K | 4.20K | |
| Other Non Operating Income (Expenses) | 2.55M | 3.21M | -2.60K | -148.42K | 9.57K |
| EBT Excluding Unusual Items | -13.74M | -16.82M | -15.90M | -5.68M | -3.71M |
| Impairment of Goodwill | -21.37M | -21.37M | |||
| Gain (Loss) on Sale of Investments | -2.50M | ||||
| Gain (Loss) on Sale of Assets | 97.32K | -288.20K | -374.97K | -2.80M | |
| Asset Writedown | -4.97M | -4.97M | |||
| Other Unusual Items | 43.20K | -53.45K | |||
| Pretax Income | -39.95M | -43.51M | -18.78M | -8.48M | -3.71M |
| Income Tax Expense | -1.99M | -1.99M | -534.40K | ||
| Earnings From Continuing Operations | -37.95M | -41.51M | -18.24M | -8.48M | -3.71M |
| Earnings From Discontinued Operations | 27.31M | -9.36M | |||
| Net Income | -37.95M | -41.51M | 9.07M | -17.84M | -3.71M |
| Net Income to Common | -37.95M | -41.51M | 9.07M | -17.84M | -3.71M |
| Shares Outstanding (Basic) | 1.17M | 613.89K | 135.01K | 30.56K | 200.00K |
| Shares Outstanding (Diluted) | 1.17M | 613.89K | 135.01K | 30.56K | 200.00K |
| EPS (Basic) | -32.46 | -67.62 | 67.15 | -583.85 | -18.54 |
| EPS (Diluted) | -32.46 | -67.62 | 67.03 | -583.85 | -18.54 |
| Free Cash Flow | -14.44M | -13.38M | -14.28M | -2.23M | -3.35M |
| Free Cash Flow Per Share | -12.35 | -21.80 | -105.75 | -72.81 | -16.76 |
| Gross Margin | 87.72% | 76.80% | 4.40% | 3.60% | 100.00% |
| Operating Margin | -1,671.08% | -3,763.77% | -10,758.70% | -322.36% | -1,213.87% |
| Profit Margin | -4,620.92% | -9,618.03% | 6,634.66% | -1,308.34% | -1,236.13% |
| Free Cash Flow Margin | -1,758.23% | -3,099.95% | -10,448.57% | -163.16% | -1,117.56% |
| EBITDA | -12.36M | -15.79M | -14.70M | -3.56M | |
| EBITDA Margin | -261.20% | ||||
| D&A For EBITDA | 1.36M | 455.85K | 2.00K | 834.16K | |
| EBIT | -13.72M | -16.24M | -14.70M | -4.40M | -3.64M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Cash & Equivalents | 8.19M | 6.66M | 308.10K | 314.00 | 604.81K |
| Cash & Short-Term Investments | 8.19M | 6.66M | 308.10K | 314.00 | 604.81K |
| Accounts Receivable | 385.31K | 731.33K | 11.11K | ||
| Other Receivables | 4.14M | 1.22M | 485.00 | ||
| Receivables | 385.31K | 731.33K | 5.45M | 2.52M | 485.00 |
| Inventory | 203.07K | 213.41K | 968.00 | ||
| Prepaid Expenses | 425.37K | 262.28K | 4.56K | 50.72K | |
| Other Current Assets | 47.38K | 542.95K | 176.35K | ||
| Total Current Assets | 9.20M | 7.92M | 6.31M | 2.75M | 605.30K |
| Property, Plant & Equipment | 16.97K | 38.86K | 218.93K | 198.72K | |
| Goodwill | 21.37M | ||||
| Other Intangible Assets | 70.07M | 70.97M | 76.40M | ||
| Long-Term Deferred Tax Assets | 534.40K | ||||
| Other Long-Term Assets | 3.45M | 250.00K | 22.04K | 9.58M | |
| Total Assets | 87.73M | 84.18M | 104.85M | 12.53M | 605.30K |
| Accounts Payable | 916.77K | 1.44M | 2.90M | 1.46M | 393.68K |
| Accrued Expenses | 503.63K | 657.03K | 1.31M | 160.21K | 83.49K |
| Short-Term Debt | 415.00K | 2.95M | |||
| Current Portion of Long-Term Debt | 1.12M | 2.29M | |||
| Current Portion of Leases | 2.55K | 24.14K | 63.33K | 32.59K | |
| Other Current Liabilities | 485.00K | 610.91K | 930.72K | 9.90M | |
| Total Current Liabilities | 3.03M | 2.74M | 7.91M | 11.56M | 3.43M |
| Long-Term Debt | 9.57M | 612.27K | |||
| Long-Term Leases | 156.47K | 176.91K | |||
| Long-Term Deferred Tax Liabilities | 11.04M | 11.04M | 13.52M | ||
| Other Long-Term Liabilities | 285.00K | 3.58M | 257.30K | ||
| Total Liabilities | 23.63M | 14.06M | 25.78M | 11.99M | 3.43M |
| Common Stock | 410.00 | 406.00 | 87.00 | 9.00 | 500.00 |
| Additional Paid-In Capital | 150.88M | 150.67M | 118.11M | 33.79M | 6.33M |
| Retained Earnings | -86.78M | -80.55M | -39.04M | -33.25M | -9.15M |
| Total Common Equity | 64.10M | 70.12M | 79.07M | 542.35K | -2.82M |
| Shareholders' Equity | 64.10M | 70.12M | 79.07M | 542.35K | -2.82M |
| Total Liabilities & Equity | 87.73M | 84.18M | 104.85M | 12.53M | 605.30K |
| Total Debt | 10.69M | 24.14K | 3.53M | 209.50K | 2.95M |
| Net Cash (Debt) | -2.50M | 6.64M | -3.22M | -209.19K | -2.35M |
| Net Cash Per Share | -2.14 | 10.81 | -23.88 | -6.84 | -11.73 |
| Filing Date Shares Outstanding | 1.64M | 1.63M | 500.60K | 56.25K | 200.00K |
| Total Common Shares Outstanding | 1.64M | 1.63M | 350.02K | 56.25K | 200.00K |
| Working Capital | 6.18M | 5.18M | -1.60M | -8.80M | -2.82M |
| Book Value Per Share | 39.03 | 43.14 | 225.91 | 9.64 | -14.11 |
| Tangible Book Value | -5.96M | -852.68K | -18.70M | 542.35K | -2.82M |
| Tangible Book Value Per Share | -3.63 | -0.52 | -53.43 | 9.64 | -14.11 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Net Income | -37.95M | -41.51M | 9.07M | -17.84M | -3.71M |
| Depreciation & Amortization | 1.39M | 491.78K | 53.36K | 1.05M | |
| Other Amortization | 2.26M | 3.16M | 912.45K | ||
| Loss (Gain) From Sale of Assets | -171.04K | 214.49K | |||
| Asset Writedown & Restructuring Costs | 26.35M | 26.35M | 5.13M | ||
| Loss (Gain) From Sale of Investments | 2.50M | ||||
| Stock-Based Compensation | 2.64M | 6.38M | 4.62M | 257.77K | 213.59K |
| Other Operating Activities | -4.97M | -5.40M | -27.84M | 9.54M | -1.00 |
| Change in Accounts Receivable | -393.46K | -720.22K | -11.11K | -293.78K | |
| Change in Inventory | -203.07K | -213.41K | 968.00 | 4.23M | |
| Change in Accounts Payable | -2.05M | -1.57M | 448.57K | 1.61M | 65.39K |
| Change in Other Net Operating Assets | -1.35M | -564.49K | -3.04M | -33.54K | 76.70K |
| Operating Cash Flow | -14.44M | -13.38M | -14.27M | -2.23M | -3.35M |
| Capital Expenditures | -12.00K | ||||
| Cash Acquisitions | 132.98K | -344.45K | |||
| Investment in Securities | -2.50M | ||||
| Other Investing Activities | 29.93M | 68.74K | |||
| Investing Cash Flow | 27.55M | -275.72K | |||
| Short-Term Debt Issued | 116.00K | 150.00K | 850.00K | ||
| Long-Term Debt Issued | 3.50M | 2.95M | 400.00K | ||
| Total Debt Issued | 14.11M | 3.62M | 3.10M | 400.00K | 850.00K |
| Short-Term Debt Repaid | -531.00K | ||||
| Long-Term Debt Repaid | -9.24M | -150.00K | |||
| Total Debt Repaid | -9.78M | -9.78M | -150.00K | ||
| Net Debt Issued (Repaid) | 4.33M | -6.16M | 3.10M | 250.00K | 850.00K |
| Issuance of Common Stock | 21.70M | 26.29M | 26.41K | 518.02K | |
| Other Financing Activities | -400.00K | -400.00K | -1.25M | 638.31K | |
| Financing Cash Flow | 25.63M | 19.73M | -12.98M | 1.41M | 850.00K |
| Net Cash Flow | 11.19M | 6.35M | 307.78K | -1.09M | -2.50M |
| Free Cash Flow | -14.44M | -13.38M | -14.28M | -2.23M | -3.35M |
| Free Cash Flow Margin | -1,758.23% | -3,099.95% | -10,448.57% | -163.16% | -1,117.56% |
| Free Cash Flow Per Share | -12.35 | -21.80 | -105.75 | -72.81 | -16.76 |
| Levered Free Cash Flow | -7.61M | -362.07K | -14.07M | 6.17M | |
| Unlevered Free Cash Flow | -7.96M | -971.17K | -14.15M | 6.88M | |
| Cash Interest Paid | 733.69K | ||||
| Change in Working Capital | -3.99M | -3.07M | -2.60M | 5.51M | 142.10K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Market Capitalization | 5.20M | 20.72M | 52.94M | ||
| Enterprise Value | 7.70M | 22.92M | 55.12M | ||
| Last Close Price | 3.22 | 12.75 | 151.25 | ||
| PE Ratio | 5.84 | ||||
| PS Ratio | 6.44 | 48.01 | 387.44 | ||
| PB Ratio | 0.08 | 0.30 | 0.67 | ||
| EV/Sales Ratio | 9.49 | 53.11 | 403.37 | ||
| Debt / Equity Ratio | 0.17 | 0.00 | 0.04 | 0.39 | -1.04 |
| Net Debt / Equity Ratio | 0.04 | -0.10 | 0.04 | 0.39 | -0.83 |
| Net Debt / EBITDA Ratio | -0.20 | 0.42 | -0.22 | -0.06 | |
| Net Debt / FCF Ratio | -0.17 | 0.50 | -0.23 | -0.09 | -0.70 |
| Asset Turnover | 0.01 | 0.01 | 0.00 | 0.21 | |
| Quick Ratio | 2.83 | 2.70 | 0.56 | 0.11 | 0.18 |
| Current Ratio | 3.04 | 2.89 | 0.80 | 0.24 | 0.18 |
| Return on Equity (ROE) | -53.47% | -55.65% | -45.83% | ||
| Return on Assets (ROA) | -8.93% | -10.74% | -15.65% | -41.83% | |
| Return on Capital Employed (ROCE) | -16.20% | -19.90% | -15.20% | -450.20% | 129.00% |
| Earnings Yield | -1,024.84% | -200.33% | 17.12% | ||
| FCF Yield | -273.03% | -64.57% | -26.97% | ||
| Buyback Yield / Dilution | -236.59% | -354.69% | -341.77% | 84.72% |